Sugi Predict

Sugi Predict / Compounds / SCHEMBL85548

SCHEMBL85548

SCHEMBL85548

O=[N+]([O-])c1ccc(N2CCOCC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.71
▸ MAPT P10636 8/20 0.70
▸ SIRT6 Q8N6T7 2/20 0.66
▸ ALDH1A1 P00352 2/20 0.66
▸ POLB P06746 2/20 0.66
▸ ADRB1 P08588 1/20 0.66
▸ KMT2A Q03164 3/20 0.62
▸ TDP1 Q9NUW8 3/20 0.62
▸ KDM4E B2RXH2 1/20 0.62
▸ GAA P10253 1/20 0.62
▸ BLM P54132 1/20 0.62
▸ CYP1A2 P05177 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ IDE P14735 1/20 0.60
▸ PKM P14618 1/20 0.59
▸ LMNA P02545 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4383897 0.93 MAPT (0.72) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL9647832 0.90 MITF (0.70) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL4690699 0.89 MAPT (0.71) AKR1C3MAPTALDH1A1KMT2ATDP1
SCHEMBL3682506 0.88 AKR1C3 (0.58) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL6151230 0.88 SIRT6 (0.81) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL15271381 0.88 SIRT6 (0.81) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL1982735 0.85 AKR1C3 (0.56) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL521556 0.84 KMT2A (0.64) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL1851861 0.84 MAPT (0.89) AKR1C3MAPTSIRT6ALDH1A1POLB
SCHEMBL378458 0.84 MAPT (0.96) AKR1C3MAPTSIRT6ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114507252-B Novel method for synthesizing arylsilane compound 广西大学 2023-10-27 — — CN claimed
CN-113135835-A Method for exciting C-C bond breaking acylation and application 广州中医药大学(广州中医药研究院) 2021-07-20 — — CN claimed
CN-108339551-A A kind of preparation method of novel antibacterial medicine linezolid intermediate 邵宏超 2018-07-31 — — CN claimed
CN-105012307-B Application of IMB5046 compound in the preparation of antineoplastic drugs 中国医学科学院医药生物技术研究所 2017-04-26 — — CN claimed
CN-105585540-A Preparation and application of novel Swern reagent UNIV ZHEJIANG TECHNOLOGY 2016-05-18 — — CN claimed
CN-102603665-A Synthesis method of 4-(4-aminophenyl)-3-morpholone BEIJING GUANHONG TECHNOLOGY GROUP CO LTD 2012-07-25 — — CN claimed
US-20110313158-A1 Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2011-12-22 — — US claimed
WO-2010097815-A2 A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-09-02 — — WO claimed
US-6379400-B1 DYEING FIBERS, SOLVENT OF WATER OR ALCOHOL AND NITROANILINE DYE WELLA AKTIENGESELLSCHAFT (DE) 2002-04-30 — — US claimed
EP-1037593-A1 AGENT AND METHOD FOR DYEING FIBRES Wella Aktiengesellschaft (DE) 2000-09-27 — — EP claimed
WO-2000021496-A1 AGENT AND METHOD FOR DYEING FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2000-04-20 — — WO claimed
US-20260137703-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECH LIMITED (GB) 2026-05-21 — — US disclosed
EP-4663630-A1 NOVEL BENZIMIDAZOLONE DERIVATIVE COMPOUND AS AUTOTAXIN INHIBITOR LG Chem, Ltd. (KR) 2025-12-17 — — EP disclosed
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 — — EP disclosed
CN-119591550-A Preparation method of molatinib and key intermediate 沈阳药科大学 2025-03-11 — — CN disclosed
EP-1037593-A1 AGENT AND METHOD FOR DYEING FIBRES Wella Aktiengesellschaft (DE) 2000-09-27 — — EP disclosed
WO-2000021496-A1 AGENT AND METHOD FOR DYEING FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2000-04-20 — — WO disclosed
US-4133672-A (Aminophenyl)morpholines and use thereof UNITED STATES BORAX & CHEMICAL CORPORATION (US) 1979-01-09 — — US disclosed
US-4133673-A HERBICIDES UNITED STATES BORAX & CHEMICAL CORPORATION (US) 1979-01-09 — — US disclosed
US-4115445-A Process for the preparation of trisubstituted ureas QUIMCO GMBH (CH) 1978-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137703-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER EGFR, KRAS, O60361 AKR1C3 1130/4885MAPT 4708/4885SIRT6 4605/4885
US-20110313158-A1 Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines HCN2, RAC2, HCN1 AKR1C3 260/4885MAPT 3456/4885SIRT6 3545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.